亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

湖北遠藥業有限公司孝南分公司  

有機原料,有機中間體,醫藥中間體,醫藥原料

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:顧亞男
  • 電話:027-50756114
  • 郵件:ycmanagers06@ycphar.com
  • 傳真:027-88048077-951
  • QQ:2355327070
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > ***三氟拉嗪
***三氟拉嗪
單價 1600.00 / KG對比
銷量 暫無
發貨 湖北武漢市付款后48小時內
庫存 6000KG起訂1KG
品牌 南箭
過期 長期有效
更新 2015-03-04 08:44
 
詳細信息

***三氟拉嗪
中文同義詞: 10-[3-(4-甲基-1-哌嗪基)丙基]-2-(三氟甲基)-10H-吩噻嗪****;***三氟拉嗪;斯的拉嗪;三氟吖嗪 ****;6-氯-7-甲基嘌呤;***甲哌氟丙嗪;三氟拉嗪****;***三氟拉嗪DI
英文名稱: Trifluoperazine dihydrochloride
英文同義詞: LABOTEST-BB LT00452002;10-[3-(4-METHYL-1-PIPERAZINYL)PROPYL]-2-TRIFLUOROMETHYL-PHENOTHIAZINE DIHYDROCHLORIDE;10-[3-(4-METHYLPIPERAZIN-1-YL)PROPYL]-2-(TRIFLUOROMETHYL)-10H-PHENOTHIAZINE DIHYDROCHLORIDE;STELAZINE;STELAZINE DIHYDROCHLORIDE;TRIFLUOPERAZINE 2HCL;TRIFLUOPERAZINE DIHYDROCHLORIDE;TRIFLUOPERAZINE HCL
CAS號: 440-17-5
分子式: C21H26Cl2F3N3S
分子量: 480.42
EINECS號: 207-123-0
性狀:
本品為白色或微黃色的結晶性粉末;無臭或幾乎無臭,味苦;微有引濕性;遇光漸變色。本品在水中易溶,在乙醇中溶解,在氯仿中微溶,在**中不溶。
熔點  243 °C (dec.)(lit.)
用途  用于治療妄想型精神分裂癥、慢性精神分裂癥、精神不安、感情紊亂、惡心、嘔吐等
包裝:25KG/紙板桶
©2025 湖北遠藥業有限公司孝南分公司 版權所有   技術支持:化工網   訪問量:23308  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |